[Cardiologic sequelae of cytostatic therapy].
As more and more oncologic patients are being cured from cancer, problems with long-term cytostatic cardiologic complications have triggered and intensive investigation. Cardiotoxicity becomes a specific problem for those who survived cancer therapy with anthracycline. Heart failure or ventricular arrhythmias may develop from subclinical myocardial alterations induced by anthracycline therapy. Long-lasting monitoring of cardiac status may help to identify those patients, whose abnormalities have progressive character and who are at risk of fatal complications.
Mladosievivcová
B
B
Oddelenie klinickej patofyziológie Ustavu patologickej fyziológie LF UK, Bratislava. mladosievic@fmed.uniba.sk
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents